Pham Quang X.'s Insider Trades & SAST Disclosures
Pham Quang X.'s most recent trade in Cadrenal Therapeutics Inc was a trade of 65,000 Stock Options done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pham Quang X..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 65,000 | 65,000 | - | - | Stock Options | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 65,000 | 65,000 | - | - | Stock Options | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Apr 2024 | 50,000 | 3,275,000 | - | 0 | Common Stock | |
| Cadrenal Therapeutics Inc | Pham Quang X. | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 150,000 | 150,000 | - | - | Stock Options | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Oct 2023 | 85,000 | 3,325,000 | - | 0 | Common Stock | |
| Cadrenal Therapeutics Inc | Quang X. Pham | Director, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 1.94 per share. | 10 Feb 2023 | 25,000 | 3,300,000 | - | 1.9 | 48,500 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges